Biotech

Theratechnologies to Announce Financial Results for the Second Quarter of 2016

MONTREAL, QUEBEC: ...

Titan Pharmaceuticals Added to Russell 3000 Index

SOUTH SAN FRANCISCO, CA: ...

Ergomed plc: US Expansion and Opening of Office in Boston

GUILDFORD, UNITED KINGDOM: ...

VBI Vaccines Begins Enrolling Patients in a Phase I Trial of its Preventative Cytomegalovirus Vaccine Candidate

CAMBRIDGE, MASSACHUSETTS: ...

Leidos Selects Immunovaccine''s DepoVax(TM) Platform to Evaluate Its USAID-Backed Malaria Vaccine Research

HALIFAX, NOVA SCOTIA: ...

Prima BioMed Announces First Safety, Pharmacokinetics and Immuno-Monitoring Data From Phase IIb Clinical Trial of IMP321

SYDNEY, AUSTRALIA: ...

IBEX Reports Results for the Third Quarter and the Nine Months Ended April 30, 2016

MONTREAL, QUEBEC: ...

Genetic Technologies Announces Appointment of Senior Medical Director

MELBOURNE, AUSTRALIA: ...

Theravance Biopharma Highlights Positive Top-Line Results From Pivotal Phase 3 FULFIL Study of the Closed Triple Announced by GlaxoSmithKline and Innoviva

DUBLIN, IRELAND: Theravance Biopharma Entitled to Receive 85% Economic Interest in Royalties Paid by GSK as Part of Agreement With Innoviva; Regulatory Submissions Planned for the Closed Triple in U.S. and EU by End o ...

Titan Pharmaceuticals Announces First Patients Treated With Probuphine(R) for Opioid Dependence

SOUTH SAN FRANCISCO, CA: More Than 1,000 Health Care Professionals Are Now Certified to Provide Probuphine ...